Table 1.
Variable |
N = 127 n (%) |
|
---|---|---|
Gender | Male | 74 (58) |
Female | 51 (40) | |
Other/do not want to say | 2 (2) | |
Location | Africa | 73 (58) |
Asia | 7 (6) | |
Europe | 43 (34) | |
Other | 4 (3) | |
Research areaa | TB | 42 (33) |
COVID-19 | 17 (13) | |
HIV | 26 (21) | |
Non-communicable diseases | 14 (11) | |
Antimicrobial resistance | 17 (13) | |
Sexual and reproductive health | 14 (11) | |
Malaria | 20 (16) | |
Other | 39 (31) | |
Not a researcher | 15 (12) | |
Career level (if researcher) | Pre-PhD | 22 (17) |
PhD student | 22 (17) | |
Early post-doc (< 4 years post-PhD) | 17 (13) | |
Senior post-doc (> 4 years post-PhD) | 22 (17) | |
Senior Scientist | 19 (15) | |
Not applicable | 25 (20) |
aMultiple research areas selected by some participants—overall tally greater than the total number of participants